Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response‐Directed High‐Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)
Pediatric Blood & Cancer2016Vol. 63(6), pp. 1125–1126
Citations Over Time
Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, Heidi Traunecker, Barry Pizer, Mark N. Gaze, Frank Saran, Nicky Thorp, Martin English, Kate Wheeler, Antony Michalski, David Walker, D.J. Saunders, Fiona Cowie, Alison Cameron, Susan Picton, Deepak Parashar, Gail Horan, M.V. Williams
Related Papers
- → Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma(2006)46 cited
- → PRMT1 is an important factor for medulloblastoma cell proliferation and survival(2022)7 cited
- THE MEDICAL IMAGING & PATHOLOGICAL ANALYSIS OF MEDULLOBLASTOMA IN CHILDREN(2006)
- → Desmoplastic medulloblastoma in an adult patient(2018)
- → Medulloblastoma: From Origin to Treatment(2020)